Literature DB >> 19556346

The 26-amino acid beta-motif of the Pit-1beta transcription factor is a dominant and independent repressor domain.

Matthew D Jonsen1, Dawn L Duval, Arthur Gutierrez-Hartmann.   

Abstract

The POU-homeodomain transcription factor Pit-1 governs the pituitary cell-specific expression of Pit-1, GH, prolactin (PRL), and TSHbeta genes. Alternative splicing generates Pit-1beta, which contains a 26-amino acid beta-domain inserted at amino acid 48, in the middle of the Pit-1 transcription activation domain (TAD). Pit-1beta represses GH, PRL, and TSHbeta promoters in a pituitary-specific manner, because Pit-1beta activates these same promoters in HeLa nonpituitary cells. Here we comprehensively analyze the role of beta-domain sequence, position, and context, to elucidate the mechanism of beta-dependent repression. Repositioning the beta-motif to the Pit-1 amino terminus, hinge, linker, and carboxyl terminus did not affect its ability to repress basal rat (r) PRL promoter activity in GH4 pituitary cells, but all lost the ability to repress Ras-induced rPRL promoter activity. To determine whether beta-domain repression is independent of Pit-1 protein and DNA binding sites, we generated Gal4-Pit-1TAD, Gal4-Pit-1betaTAD, and Gal4-beta-domain fusions and demonstrated that the beta-motif is sufficient to actively repress VP16-mediated transcription of a heterologous promoter. Moreover, beta-domain point mutants had the same effect whether fused to Gal4 or within the context of intact Pit-1beta. Surprisingly, Gal4-beta repression lost histone deacetylase sensitivity and pituitary specificity. Taken together, these results reveal that the beta-motif is a context-independent, modular, transferable, and dominant repressor domain, yet the beta-domain repressor activity within Pit-1beta contains cell type, promoter, and Pit-1 protein context dependence.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19556346      PMCID: PMC2737555          DOI: 10.1210/me.2008-0137

Source DB:  PubMed          Journal:  Mol Endocrinol        ISSN: 0888-8809


  55 in total

Review 1.  Coactivator and corepressor complexes in nuclear receptor function.

Authors:  L Xu; C K Glass; M G Rosenfeld
Journal:  Curr Opin Genet Dev       Date:  1999-04       Impact factor: 5.578

2.  The pituitary-specific transcription factor, Pit-1, can direct changes in the chromatin structure of the prolactin promoter.

Authors:  Paul Kievit; Richard A Maurer
Journal:  Mol Endocrinol       Date:  2004-09-16

3.  Pit-1beta reduces transcription and CREB-binding protein recruitment in a DNA context-dependent manner.

Authors:  A L Ferry; D M Locasto; L B Meszaros; J C Bailey; M D Jonsen; K Brodsky; C J Hoon; A Gutierrez-Hartmann; S E Diamond
Journal:  J Endocrinol       Date:  2005-04       Impact factor: 4.286

4.  Synthesis of turkey Pit-1 mRNA variants by alternative splicing and transcription initiation.

Authors:  K Kurima; K L Weatherly; L Sharova; E A Wong
Journal:  DNA Cell Biol       Date:  1998-01       Impact factor: 3.311

5.  Interaction between estrogen receptor and Pit-1 protein is influenced by estrogen in pituitary cells.

Authors:  C Ying; D H Lin; D K Sarkar; T T Chen
Journal:  J Steroid Biochem Mol Biol       Date:  1999-02       Impact factor: 4.292

6.  The transcription factor GHF-1, but not the splice variant GHF-2, cooperates with thyroid hormone and retinoic acid receptors to stimulate rat growth hormone gene expression.

Authors:  A Sánchez-Pacheco; P Peña; T Palomino; A Güell; J L Castrillo; A Aranda
Journal:  FEBS Lett       Date:  1998-01-23       Impact factor: 4.124

7.  Synergistic activation of the prolactin promoter by vitamin D receptor and GHF-1: role of the coactivators, CREB-binding protein and steroid hormone receptor coactivator-1 (SRC-1).

Authors:  A I Castillo; A M Jimenez-Lara; R M Tolon; A Aranda
Journal:  Mol Endocrinol       Date:  1999-07

8.  Growth inhibition by the tumor suppressor p33ING1 in immortalized and primary cells: involvement of two silencing domains and effect of Ras.

Authors:  Frauke Goeman; Dorit Thormeyer; Maria Abad; Manuel Serrano; Oliver Schmidt; Ignacio Palmero; Aria Baniahmad
Journal:  Mol Cell Biol       Date:  2005-01       Impact factor: 4.272

9.  Reconstitution of the protein kinase A response of the rat prolactin promoter: differential effects of distinct Pit-1 isoforms and functional interaction with Oct-1.

Authors:  S E Diamond; M Chiono; A Gutierrez-Hartmann
Journal:  Mol Endocrinol       Date:  1999-02

10.  Signal-specific co-activator domain requirements for Pit-1 activation.

Authors:  L Xu; R M Lavinsky; J S Dasen; S E Flynn; E M McInerney; T M Mullen; T Heinzel; D Szeto; E Korzus; R Kurokawa; A K Aggarwal; D W Rose; C K Glass; M G Rosenfeld
Journal:  Nature       Date:  1998-09-17       Impact factor: 49.962

View more
  5 in total

Review 1.  Function of alternative splicing.

Authors:  Olga Kelemen; Paolo Convertini; Zhaiyi Zhang; Yuan Wen; Manli Shen; Marina Falaleeva; Stefan Stamm
Journal:  Gene       Date:  2012-08-15       Impact factor: 3.688

Review 2.  The prolactin gene: a paradigm of tissue-specific gene regulation with complex temporal transcription dynamics.

Authors:  K Featherstone; M R H White; J R E Davis
Journal:  J Neuroendocrinol       Date:  2012-07       Impact factor: 3.627

3.  RanBPM is an inhibitor of ERK signaling.

Authors:  Elnaz Atabakhsh; Caroline Schild-Poulter
Journal:  PLoS One       Date:  2012-10-31       Impact factor: 3.240

4.  A 5'-regulatory region and two coding region polymorphisms modulate promoter activity and gene expression of the growth suppressor gene ZBED6 in cattle.

Authors:  Yong-Zhen Huang; Ming-Xun Li; Jing Wang; Zhao-Yang Zhan; Yu-Jia Sun; Jia-Jie Sun; Cong-Jun Li; Xian-Yong Lan; Chu-Zhao Lei; Chun-Lei Zhang; Hong Chen
Journal:  PLoS One       Date:  2013-11-06       Impact factor: 3.240

5.  High-throughput splicing assays identify missense and silent splice-disruptive POU1F1 variants underlying pituitary hormone deficiency.

Authors:  Peter Gergics; Cathy Smith; Hironori Bando; Alexander A L Jorge; Denise Rockstroh-Lippold; Sebastian A Vishnopolska; Frederic Castinetti; Mariam Maksutova; Luciani Renata Silveira Carvalho; Julia Hoppmann; Julián Martínez Mayer; Frédérique Albarel; Debora Braslavsky; Ana Keselman; Ignacio Bergadá; Marcelo A Martí; Alexandru Saveanu; Anne Barlier; Rami Abou Jamra; Michael H Guo; Andrew Dauber; Marilena Nakaguma; Berenice B Mendonca; Sajini N Jayakody; A Bilge Ozel; Qing Fang; Qianyi Ma; Jun Z Li; Thierry Brue; María Ines Pérez Millán; Ivo J P Arnhold; Roland Pfaeffle; Jacob O Kitzman; Sally A Camper
Journal:  Am J Hum Genet       Date:  2021-07-15       Impact factor: 11.025

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.